Literature DB >> 22284730

The molecular pathology of Alzheimer's disease.

Charles R Harrington1.   

Abstract

Neurofibrillary pathology in Alzheimer's disease consists of paired helical filaments comprising tau protein. This pathology is correlated with dementia, but can appear in the first two decades of life. Extracellular amyloid β-protein arises through proteolytic processing of a transmembrane precursor, which involves the action of several enzymes. Mutations in the genes for the precursor and presenilin proteins accelerate the deposition of Aβ. Tau mutations cause other tauopathies in the absence of amyloid deposition, indicating that amyloid deposition is not a prerequisite for dementia. An improved understanding of Alzheimer's disease awaits to be obtained by molecular imaging of these pathologies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284730     DOI: 10.1016/j.nic.2011.11.003

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  17 in total

1.  Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.

Authors:  Maricarmen Hernández-Rodríguez; Ivonne Maciel Arciniega-Martínez; Iohanan Daniel García-Marín; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  Mol Neurobiol       Date:  2020-07-07       Impact factor: 5.590

2.  Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.

Authors:  Hongxin Dong; Shirlene Wang; Ziling Zeng; Fei Li; Janitza Montalvo-Ortiz; Christopher Tucker; Shahzad Akhtar; Jingshan Shi; Herbert Y Meltzer; Kenner C Rice; John G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  2014-05-27       Impact factor: 4.530

Review 3.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

4.  Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice.

Authors:  Gehad M Subaiea; Lina I Adwan; Aseef H Ahmed; Karen E Stevens; Nasser H Zawia
Journal:  Neurobiol Aging       Date:  2013-04-30       Impact factor: 4.673

5.  The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease.

Authors:  Amanda J Brock; Anne Kasus-Jacobi; Megan Lerner; Sreemathi Logan; Adekunle M Adesina; H Anne Pereira
Journal:  Histochem Cell Biol       Date:  2015-07-14       Impact factor: 4.304

Review 6.  Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives.

Authors:  Mina Park; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

7.  The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.

Authors:  Sahar Andarzi Gargari; Abolfazl Barzegar; Alireza Tarinejad
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

Review 8.  Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?

Authors:  Jaime M Ross; Lars Olson; Giuseppe Coppotelli
Journal:  Int J Mol Sci       Date:  2015-08-17       Impact factor: 5.923

Review 9.  Sirtuin deacetylases as therapeutic targets in the nervous system.

Authors:  Brett Langley; Anthony Sauve
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

10.  Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio.

Authors:  Ting-Hai Xu; Yan Yan; Yanyong Kang; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Cell Discov       Date:  2016-08-23       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.